Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT04520971Not ApplicableCompleted

Closed-loop Insulin Delivery in Pregnant Women With Type 1 Diabetes

Role: collaborator

NCT05771493Completed

The Spinopelvic Parameters, Body Mass Index and Waist Circumference in Patientd Chronic Non-specific Low Back Pain

Role: lead

NCT05095064Unknown

Retrospective Study on the Efficacy and Tolerability of Liposomal Irinotecan

Role: collaborator

NCT05022745Phase 4Unknown

ERAS Protocol for Single-level Posterior Lumbar Arthrodesisprospective Study.

Role: lead

NCT04473027Terminated

BLood Groups as Biomarker to Optimize Odds of Response to Anti-PD-1 Drugs

Role: collaborator

NCT04500691Completed

pRedicting the Long-term rEsponse of High Frequency sPinal cOrd sTimulation in Patients With Failed Back Surgery Syndrome.

Role: collaborator

NCT01619592Not ApplicableCompleted

Web-based Education for Diabetes Patients on Adaptable Insulin Schedules

Role: collaborator

All 7 trials loaded